This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cantrell Selected To Lead Kansas Bioscience Authority

OLATHE, Kan., Nov. 20, 2012 /PRNewswire/ -- The Kansas Bioscience Authority unanimously approved the naming of Duane Cantrell to serve as its president and CEO, KBA Board Chairman Dan Watkins announced today.

Cantrell is currently managing partner of Genus Consulting, LLC, a retail consulting firm.  Prior to that, he worked at Payless ShoeSource, Inc., for 26 years, serving as the company's president from 2001-04.

"Duane brings a wealth of executive experience to KBA's efforts to grow the Kansas bioscience economy.  He knows how to grow companies in tough competitive environments and has the skills and values which will serve our mission well," said Watkins.

"I am excited about the opportunity with the Kansas Bioscience Authority to contribute to the economic development of the state of Kansas, helping create and attract high growth bioscience companies and jobs.  Especially in a difficult economic climate, the KBA can play a key role building on a quality workforce, our educational institutions and our unique human and animal health corridors which make Kansas an obvious choice," said Cantrell.

Cantrell is chairman of the Kansas State University Foundation Board of Trustees.  He also serves as chairman of the board of directors for Hiper Technology, a carbon fiber plastics manufacturer, and as chairman of the board for GTM Sportswear.

He has a bachelor's degree in economics from Kansas State University, and in 1997 graduated from the University of Virginia's Darden Graduate School of Business' executive program.  He and his wife, Leslee, live in Topeka.

David Vranicar, who has been serving as president and CEO of the KBA since April 2011 will remain with the KBA in a key role continuing to advance its mission.  "David has provided great leadership to the KBA during a challenging period for our organization," said Watkins.

The Kansas Bioscience Authority was created by the Kansas Economic Growth Act of 2004 to advance the state's leadership in bioscience.  It focuses the development of opportunities in agriculture and bio-based products, animal health, bio energy and human health.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs